Cargando…
N6-methyladenine-modified DNA was decreased in Alzheimer’s disease patients
BACKGROUND: In recent years, the prevalence of Alzheimer’s disease (AD) has increased, which places a great burden on society and families and creates considerable challenges for medical services. N6-methyladenine (m6A) deoxyribonucleic acid (DNA) adenine methylation is a novel biomarker and is abun...
Autores principales: | Lv, Shuang, Zhou, Xiao, Li, Yi-Ming, Yang, Tao, Zhang, Shu-Juan, Wang, Yu, Jia, Shu-Hong, Peng, Dan-Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771380/ https://www.ncbi.nlm.nih.gov/pubmed/35097069 http://dx.doi.org/10.12998/wjcc.v10.i2.448 |
Ejemplares similares
-
DNA N(6)-methyladenine modification in hypertension
por: Guo, Ye, et al.
Publicado: (2020) -
No evidence for DNA N(6)-methyladenine in mammals
por: Douvlataniotis, Karolos, et al.
Publicado: (2020) -
DNA N6-Methyladenine Modification in Eukaryotic Genome
por: Li, Hao, et al.
Publicado: (2022) -
Characteristics and functions of DNA N(6)-methyladenine in embryonic chicken muscle development
por: Yang, Maosen, et al.
Publicado: (2023) -
N(6)-methyladenine in DNA antagonizes SATB1 in early development
por: Li, Zheng, et al.
Publicado: (2020)